Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. They use state of the art synthetic biology and bioinformatic computational analysis to customize exosomes (extracellular vesicles) derived from probiotics.

Versatope Therapeutics is committed to revolutionizing immuno-therapy for infectious diseases, allergy and cancer. Their exosomes can deliver therapeutics (proteins, nucleic acids, carbohydrates or antibodies) that are engineered to modulate immune responses for multiple diseases.